Skip to main content

Dr. David E. Mccune, M.D.

Hematology & Oncology (Hematology & Oncology Physician)

  • Medicare participating

At a glance

Medical school
Baylor College of Medicine (1992)
Years since graduation
34
In the NPI registry since
2006
Medicare patients seen, 2024
268

Licensed in Washington since 2000, according to the Washington State Department of Health. We show license dates only for the states that publish them in bulk; see which states do. For other states, check the state medical board.

The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is

Education and training

  • 1992Medical school: Baylor College of Medicine
  • 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier

Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).

Specialties and state licenses

  • Hematology & Oncology Physician primary
    WA license MD00038264 (first issued 2000; active)

As reported to the NPI registry. To confirm a license is current, check the state medical board.

Map: Hematology & Oncology per capita by county →

Where they work

Hospitals

Medical groups

Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.

Medicare patients and services

Medicare patients, 2024
268
Services billed
70,808
Patients’ average age
75
Most frequent Medicare services, 2023
ServiceTimesPatients
Injection, filgrastim-aafi, biosimilar, (nivestym), 1 microgram27,66023
Injection, pembrolizumab, 1 mg9,20011
Injection, fosaprepitant, 1 mg4,95016
Injection, dexamethasone sodium phosphate, 1 mg56227
Injection, palonosetron hcl, 25 mcg36017
Administration of chemotherapy into vein, 1 hour or less14147
Established patient office or other outpatient visit, 30-39 minutes12359
Injection of drug or substance under skin or into muscle12251
Injection of additional new drug or substance into vein11434
Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less8127

Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.

Medicare prescriptions

Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.

Payments from drug and device companies

In 2025, 26 companies reported 76 payments worth $1,540 in total to this clinician.

By company
AstraZeneca Pharmaceuticals LP$219
Daiichi Sankyo Inc.$202
AbbVie Inc.$153
Genzyme Corporation$93.97
Janssen Biotech, Inc.$92.03
Stemline Therapeutics Inc.$76.21
Syndax Pharmaceuticals, Inc.$75.39
Taiho Oncology, Inc.$71.52
By type
Food and Beverage$1,540

From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.

Who received the most in Washington →

Other Hematology & Oncology clinicians in Tacoma

Sources

NPI registry (CMS NPPES, November 2026; record last updated July 9, 2007), Medicare Care Compare, Medicare Physician & Other Practitioners (2024), Medicare Part D Prescribers (2024) and Open Payments (2025). Information is self-reported or billed data and may be out of date; call before visiting.

NPI 1457366320. Official NPI registry record (opens in a new tab). Clinicians can correct their information in NPPES; changes appear here after our next monthly update.